Skip to content
News, Announcements and Expert Commentary from Inova

Posts Tagged ‘Jeanny Aragon-Ching’

New Treatment Options Are Changing the Landscape for Prostate Cancer Patients

Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Prostate cancer is an extremely common disease. More than 3 million…

Read More

Treatment Innovation for Patients with Prostate, Bladder and Kidney Cancers

 Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers.   The doctors and researchers at the Inova Schar Cancer…

Read More

Do You Know the Warning Signs of Bladder Cancer?

Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Read Dr. Aragon-Ching’s profile.  Bladder cancer doesn’t get the attention that…

Read More

Inova Schar Cancer Institute Oncologist Jeanny Aragon-Ching Selected for ASCO Leadership Development Program

inova logo

FALLS CHURCH, VA – Inova is pleased to announce that Jeanny Aragon-Ching, MD, has been selected to participate in the esteemed American Society of Clinical Oncology (ASCO) Leadership Development Program for years 2017-2018. The ASCO Leadership Development Program is a year-long course for a mid-career group of highly accomplished practicing oncologists. It positions them to…

Read More

Inova Dwight and Martha Schar Cancer Institute Names Leading Experts in Cancer Care, Research and Administration

inova logo

Inova Dwight and Martha Schar Cancer Institute (ISCI) names Jeanny Aragon-Ching, MD, Clinical Program Director of Genitourinary Cancers and (ISCI) names Thomas Graves, FACHE, Vice President for Cancer Services and ISCI Associate Director for Administration FALLS CHURCH, VA – October 28, 2015 – Inova today announced the addition of two leaders who will bring new…

Read More

Prostate Cancer Is the Second Most Common Cancer in American Men

Dr. Aragon-Ching serves as the Clinical Program Director of Genitourinary Cancers within the Inova Dwight and Martha Schar Cancer Institute. Schedule an appointment or learn more about Dr. Aragon-Ching. Prostate Cancer Awareness Month Prostate cancer is the most common cancer, apart from skin cancer, that occurs among American men. In 2015 alone, a projected 220,000…

Read More